Is irbesartan 150 mg equivalent to losartan 100 mg?

Irbesartan 150mg vs Losartan 100mg: Not Equivalent

Irbesartan 150 mg and losartan 100 mg are not equivalent doses; irbesartan 150 mg provides comparable or slightly inferior blood pressure reduction compared to losartan 100 mg, while irbesartan 300 mg is superior to losartan 100 mg. 1, 2

Dose Equivalence Based on Clinical Evidence

Direct Comparative Studies

The most relevant head-to-head trials demonstrate clear dose-response relationships:

• Irbesartan 150 mg vs Losartan 100 mg: In a randomized double-blind study of 567 patients, irbesartan 150 mg showed no significant difference in blood pressure reduction compared to losartan 100 mg throughout the 8-week study period 1

• Irbesartan 300 mg vs Losartan 100 mg: The same study showed irbesartan 300 mg produced significantly greater reductions in both systolic and diastolic blood pressure compared to losartan 100 mg—by 5.1 mmHg and 3.0 mmHg respectively (P < 0.01 for both) 1

• Elective Titration Study: In 432 patients, irbesartan monotherapy (150-300 mg) achieved greater mean trough diastolic blood pressure reduction (-10.2 mmHg) compared to losartan monotherapy (50-100 mg, -7.9 mmHg) at week 8 2

Guideline-Recommended Dosing

According to the 2017 ACC/AHA Hypertension Guidelines:

• Irbesartan: Usual dose range is 150-300 mg once daily 3
• Losartan: Usual dose range is 50-100 mg once daily (can be given 1-2 times daily) 3
• FDA-approved starting dose for irbesartan: 150 mg once daily, with maximum dose of 300 mg 4

Pharmacologic Differences Explaining Non-Equivalence

Key Pharmacokinetic Distinctions

• Bioavailability: Irbesartan has 60-80% oral bioavailability with no food effect, while losartan requires hepatic conversion to an active metabolite 4, 5

• Half-life: Irbesartan has a terminal elimination half-life of 11-15 hours, providing more sustained AT1 receptor blockade 4

• Receptor Binding: Irbesartan demonstrates insurmountable, specific AT1 receptor blockade with greater affinity (>8500-fold) for AT1 vs AT2 receptors 4, 5

• Duration of Action: Single doses of irbesartan 150 mg maintain 60% inhibition of angiotensin II pressor effects at 24 hours, compared to 40% with some comparators 4

Clinical Implications for Practice

Appropriate Dose Selection

For equivalent antihypertensive efficacy to losartan 100 mg, prescribe irbesartan 300 mg once daily 1, 6

• Irbesartan 150 mg is roughly equivalent to losartan 50-100 mg 1
• The maximum effective dose of irbesartan (300 mg) outperforms the maximum dose of losartan (100 mg) 1, 6

Special Considerations

• Volume-depleted patients: Start irbesartan at 75 mg once daily 4
• Diabetic nephropathy: Irbesartan 300 mg is the recommended dose for renal protection 4, 7
• Cost-effectiveness: Irbesartan has demonstrated superior cost-effectiveness over losartan in multiple country-specific evaluations 6, 7

Unique Pharmacologic Properties

• Uric acid: Losartan uniquely decreases serum uric acid levels (63 μmol/L reduction) compared to irbesartan (12 μmol/L reduction, P < 0.0001), which may be relevant in hyperuricemic patients 8

• Tolerability: Irbesartan 300 mg was associated with the lowest incidence of adverse events and discontinuations in comparative trials 1

Common Pitfalls to Avoid

• Do not assume 1:1 dose equivalence between different ARBs based on their position in the dose range 1, 2
• Do not use irbesartan 150 mg when switching from losartan 100 mg if maximal blood pressure control was achieved; use irbesartan 300 mg instead 1, 6
• Consider the clinical context: While irbesartan 300 mg is more effective for blood pressure reduction, losartan may be preferred in patients with concurrent hyperuricemia or gout 8